#TENX hashtag - Bluesky

3 weeks ago

wtv i might as well post this right now

whipped this up in resolve real quick, here's all the old sfx i made and will be remaking soon. CW is in the video
#TENX #exe #exeoc #sfx

6 5 1 0

2 months ago

OK OK. last post about this old version then i'm moving on. here were some old concepts for the layout of his realm.
beware i talk about slightly brutal stuff in here, not very descriptive though #exe #exeoc #TENX

6 3 1 1

2 months ago

here are some scrapped concepts for characters, they'll all be getting reworks for the new version #TENX #exe #exeoc

10 4 1 1

2 months ago

tried removing the roblox aspect of TENX so this is how he'd look as a normal exe #sonicexe #exe #exeoc #TENX
new tag for this version will be #missing2010

19 5 2 2

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment Tenax Therapeutics (NASDAQ: TENX) reported that a prespecified blinded sample size re-estimation (BSSR) for the Phase 3 LEVEL trial showed the study is powered at >90% to detect a 25-meter change in 6-minute walk distance (6MWD), with observed standard deviation in the first 150 randomized patients below the assumed 55 meters. Tenax confirmed no increase in target enrollment and reiterated that LEVEL enrollment is expected to complete in the first half of 2026, with topline data expected in the second half of 2026.The company also initiated LEVEL-2, a global Phase 3 trial planning ~540 patients randomized 2:1 (TNX-103 vs placebo) with primary endpoint 6MWD at Week 26, selecting >100 sites across 15 countries and estimating enrollment completion by end of 2027. Tenax will open a global open-label extension to provide continued access to TNX-103.

3 months ago

#TENX Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

4 months ago

This analyst loves Tenax Therapeutics Roth Capital Markets analyst Jonathan Aschoff has maintained his “Buy” rating and US$30.00 price target on Tenax Therapeutics

This analyst loves Tenax Therapeutics Roth Capital Markets analyst Jonathan Aschoff maintained his “Buy” rating and US$30.00 price target on Tenax Therapeutics (Tenax Therapeutics Stock Quote, ...

#All #posts #American #Tech #Analysts #tenx

Origin | Interest | Match

0 0 0 0

4 months ago

#TENX Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0

4 months ago

i really wanna make more art of my exe ocs (specifically #TENX) but i'm still working on 16sinisterdays so

3 1 1 0

5 months ago

a google image of a streetlamp illuminating a snowy pathway. a man with a wide brimmed hat is standing behind the visibility the light is providing, barely visible. it's really low quality

#exetober D26 - reality | ft. Standman from TENX by me

You're running. You need to calm down.
(i've yet to show off this guy's design i just really wanted to use him, so this is technically his debut)
#exe #exeoc #execommunity #edit #imageedit #TENX

4 4 1 0

5 months ago

G.O.R.E. holding TENX's face passionately, a white glow surrounds them both. TENX is doing the "Yaranaika?" meme face. captions say "NO TENX.. I WON'T LET YOU DIE LIKE THIS!!!" and TENX says "Ha.. you're such a bad liar... G.O.R.E. ..."

#exetober D23 - bittersweet | ft. TENX and G.O.R.E.

i did NOT know wtf to do for this one (this is a joke please)
#sonicexe #exe #exeoc #execommunity #fastfun #TENX #yaoi

6 4 1 0

5 months ago

a child sitting at a desk playing on a dated computer (~2010). the face of TENX seems to be looming behind the computer and desk. text reads as follows: "I DON'T KNOW WHAT TO DO" "NO" "HE'S BEEN IN HIS ROOM FOR DAYS" "..KED THE DOOR FROM THE INSIDE AND.." "..ASE COME HOME"

#exetober D20 - inside of your mind | ft. TENX by me

i'm still running out of ideas. this is somewhat lore-related to TENX's story but oh well
#exe #exeoc #execommunity #TENX

2 2 1 0

European Patent Office to Grant 17-Year Protection: Tenax's Breakthrough Heart Failure Drug TNX-103 Tenax Therapeutics secures European patent protection until 2040 for levosimendan in PH-HFpEF treatment. Coverage includes oral TNX-103, multiple delivery methods, and combination therapies.

6 months ago

#TENX Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0

Tenax's Heart Failure Drug Trial Grows Larger: Company Reveals Strong $105M Cash Position Through 2027 Biotech firm expands Phase 3 PH-HFpEF trial enrollment target to 230 patients, pushing completion to 2026. Second Phase 3 study launching as cash reserves hit $105.5M. Learn more.

7 months ago

#TENX Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0

8 months ago

colored references from left to right, TENX's husk form, a faceless roblox guest with a distorted "ROBLOX" logo on his chest, wearing an orange skate helmet with checkers going down the middle TENX's faker form, a 4'10" anthro robloxian with white fur, floppy dog ears, fluffy tail and paws, wearing black harem pants, black boots, and a black turtleneck sweater with a "GUEST" logo on the front TENX's true form, a 11'10" void creature with a bony, thin body, a long large mane of polygonal void spikes, a dark grey "ROBLOX" logo across his torso and arms, and a light grey square shaped face with large black pupils roblox references of the character's original designs are in the upper left corner, made in generic zombie apocalypse rp on roblox text in the middle reads "heights are not accurate"

anyways, wanted to make a thread for this guy
his name is TENX and he's basically just 2011x if he chose roblox in 2010 instead of sonic in 2011
#sonicexe (kinda) #exe #oc #exeoc #ocref #roblox #robloxcreepypasta #robloxoc #story #writing #lore (ig) #TENX

11 2 2 1

Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update Tenax Therapeutics (NASDAQ: TENX) reported its Q1 2025 financial results and provided updates on its Phase 3 clinical trials. The company expects to complete enrollment of 230 patients in its Phase 3 LEVEL study for TNX-103 in PH-HFpEF by year-end 2025, with topline data expected mid-2026. A second Phase 3 study, LEVEL-2, is planned to commence in 2025.Financial highlights include: cash position of $111.4 million as of March 31, 2025, bolstered by a $25 million private placement in March 2025. Q1 2025 saw increased expenses with R&D costs at $5.7 million (up from $2.7M in Q1 2024) and G&A expenses at $5.7 million (up from $1.2M). Net loss widened to $10.4 million compared to $3.8M in Q1 2024. The company expects current cash to fund operations through 2027.

10 months ago

#TENX Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0

Tenax Raises Massive $125M War Chest: Phase 3 Heart Failure Drug Trial Gets Major Boost Tenax strengthens financial position with $125M raise, extends runway through 2027. Enhanced Phase 3 LEVEL study for PH-HFpEF drug advancing with expanded protocol.

1 year ago

#TENX Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0

Tenax Therapeutics Secures $25 Million From RTW Investments For Phase 3 Clinical Trials Biotech firm raises strategic capital from RTW Investments to advance Phase 3 clinical programs, strengthening its financial position with minimal dilution.

1 year ago

#TENX Tenax Therapeutics Announces $25 Million Private Placement

www.stocktitan.net/news/TENX/tenax-therapeu...

0 0 0 0